Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Miki Nishitani, M.D.

Concepts (84)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Miki Nishitani's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Miki Nishitani has written about over time.
Serine Endopeptidases, 2 publications between 2009 and 2011, average publication date July 2010. Complement C4, 1 publications between 2012 and 2012, average publication date August 2012. Adrenal Hyperplasia, Congenital, 3 publications between 2012 and 2013, average publication date October 2012. Steroid 21-Hydroxylase, 2 publications between 2012 and 2013, average publication date October 2012. Tenascin, 2 publications between 2012 and 2013, average publication date October 2012. Ehlers-Danlos Syndrome, 1 publications between 2013 and 2013, average publication date January 2013. Haploinsufficiency, 1 publications between 2013 and 2013, average publication date January 2013. Acyclovir, 1 publications between 2021 and 2021, average publication date May 2021. Herpes Simplex, 1 publications between 2021 and 2021, average publication date May 2021. Pregnancy Complications, Infectious, 1 publications between 2021 and 2021, average publication date May 2021. Hepatic Veno-Occlusive Disease, 1 publications between 2022 and 2022, average publication date November 2022. Hematology, 1 publications between 2023 and 2023, average publication date January 2023. Medical Oncology, 1 publications between 2023 and 2023, average publication date January 2023. Education, Medical, Graduate, 2 publications between 2023 and 2023, average publication date February 2023. Fellowships and Scholarships, 2 publications between 2023 and 2023, average publication date February 2023. DEAD-box RNA Helicases, 1 publications between 2024 and 2024, average publication date May 2024. Pulmonary Blastoma, 1 publications between 2024 and 2024, average publication date May 2024. Ribonuclease III, 1 publications between 2024 and 2024, average publication date May 2024. Sarcoma, 1 publications between 2024 and 2024, average publication date May 2024.

To see the data from this visualization as text, click here.
Nishitani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (84)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.